{"id":603847,"date":"2009-10-28T13:14:08","date_gmt":"2009-10-28T17:14:08","guid":{"rendered":"http:\/\/www.pehub.com\/?p=53988"},"modified":"2009-10-28T13:14:08","modified_gmt":"2009-10-28T17:14:08","slug":"nodality-raising-new-round","status":"publish","type":"post","link":"https:\/\/mereja.com\/index\/603847","title":{"rendered":"Nodality Raising New Round"},"content":{"rendered":"<p><strong>Nodality Inc.<\/strong> of South San Francisco has secured $3.5 million of a $10 million funding round, according to a regulatory filing. Past backers have included Kleiner Perkins Caufield &amp; Byers, Maverick Capital and TPG Biotech Partners. According to the TPG website, Nodality focuses on &#8220;personal diagnostics targeting cell-signaling pathway \u201cnodes\u201d detected in well defined cellular sub-populations from individual patients.&#8221; <a href=\"http:\/\/www.nodalityinc.com\">www.nodalityinc.com<\/a><\/p>\n<p><a href=\"http:\/\/sharethis.com\/item?&wp=2.6.2&amp;publisher=cc2b1207-de99-4484-bf7a-c797973e9397&amp;title=Nodality+Raising+New+Round&amp;url=http%3A%2F%2Fwww.pehub.com%2F53988%2Fnodality-raising-new-round%2F\">ShareThis<\/a><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/tvcEFDkU3amRDUGRdEKceIEBOQc\/0\/da\"><img src=\"http:\/\/feedads.g.doubleclick.net\/~a\/tvcEFDkU3amRDUGRdEKceIEBOQc\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br\/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/tvcEFDkU3amRDUGRdEKceIEBOQc\/1\/da\"><img src=\"http:\/\/feedads.g.doubleclick.net\/~a\/tvcEFDkU3amRDUGRdEKceIEBOQc\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p><div class=\"feedflare\">\n<a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=9VVUF8jbhXc:bHUTgwKYt2E:yIl2AUoC8zA\"><img src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=yIl2AUoC8zA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=9VVUF8jbhXc:bHUTgwKYt2E:dnMXMwOfBR0\"><img src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=dnMXMwOfBR0\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=9VVUF8jbhXc:bHUTgwKYt2E:D7DqB2pKExk\"><img src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?i=9VVUF8jbhXc:bHUTgwKYt2E:D7DqB2pKExk\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=9VVUF8jbhXc:bHUTgwKYt2E:7Q72WNTAKBA\"><img src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=7Q72WNTAKBA\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=9VVUF8jbhXc:bHUTgwKYt2E:V_sGLiPBpWU\"><img src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?i=9VVUF8jbhXc:bHUTgwKYt2E:V_sGLiPBpWU\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=9VVUF8jbhXc:bHUTgwKYt2E:qj6IDK7rITs\"><img src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=qj6IDK7rITs\" border=\"0\"><\/img><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?a=9VVUF8jbhXc:bHUTgwKYt2E:l6gmwiTKsz0\"><img src=\"http:\/\/feeds.feedburner.com\/~ff\/pehub\/news\/all?d=l6gmwiTKsz0\" border=\"0\"><\/img><\/a>\n<\/div><img src=\"http:\/\/feeds.feedburner.com\/~r\/pehub\/news\/all\/~4\/9VVUF8jbhXc\" height=\"1\" width=\"1\"\/>","protected":false},"excerpt":{"rendered":"<p>Nodality Inc. of South San Francisco has secured $3.5 million of a $10 million funding round, according to a regulatory filing. Past backers have included Kleiner Perkins Caufield &amp; Byers, Maverick Capital and TPG Biotech Partners. According to the TPG website, Nodality focuses on &#8220;personal diagnostics targeting cell-signaling pathway \u201cnodes\u201d detected in well defined cellular [&hellip;]<\/p>\n","protected":false},"author":288,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"advanced_seo_description":"","jetpack_seo_html_title":"","jetpack_seo_noindex":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[4821],"tags":[],"class_list":["post-603847","post","type-post","status-publish","format-standard","hentry","category-news"],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p9NivD-2x5t","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/posts\/603847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/users\/288"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/comments?post=603847"}],"version-history":[{"count":0,"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/posts\/603847\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/media?parent=603847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/categories?post=603847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.com\/index\/wp-json\/wp\/v2\/tags?post=603847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}